Comparisons of oxidative metabolism and reductive capacity in sulfonamide-tolerant and -intolerant patients with human immunodeficiency virus

Journal of Clinical Pharmacology

Volumn 36, Issue 12, 1996, Pages 1149-1153

  Lehmann, David F ^a,b   Holohan, Peter D ^a   Blair, Donald C ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CAFFEINE; CIMETIDINE; COTRIMOXAZOLE; CYSTEINE; CYTOCHROME P450;

ADULT; AMINO ACID BLOOD LEVEL; ANAPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG HYPERSENSITIVITY; DRUG METABOLISM; DRUG OXIDATION; DRUG TOLERANCE; ENZYME ACTIVITY; ERYTHEMA MULTIFORME; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0030454643     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1996.tb04169.x     Document Type: Article

References (21)

1. Schneider MM, Hoepelman AI, Schattenkerk JK, et al: A controlled trial of aerosolized pentamidine or trimethoprim - sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency infection. N Engl J Med 1992;327:1836-1841.
2. Medina I, Mills J, Leoung G, et al: Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a controlled trial of trimethoprim - sulfamethoxazole versus trimethoprim - dapsone. N Engl J Med 1990;323:776-782.
3. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W: Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986;105:179-184.
4. van der Ven AJ, Koopmans PP, Vree TB, van der Meer JW: Adverse reactions to cotrimoxazole in HIV infection. Lancet 1991;338:431-433.
5. Rieder MJ, Uetrecht J, Shear NH, Cannon M, Miller, M., Spielberg SP: Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites. Ann Intern Med 1989;110:286-289.
6. Cribb AE, Miller M, Leeder S, Hill J, Spielberg SP: Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Drug Metab Dispos 1991;19:900-906.
7. Carr A, Gross AS, Hoskins JM, Penny R, Cooper DA: Acetylation phenotype and cutaneous hypersensitivity to trimethoprim - sulphamethoxazole in HIV-infected patients. AIDS 1994;8:333-337.
8. Lee BL, Wong D, Benowitz NL, Sullam PM: Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome. Clin Pharmacol Ther 1993;53:529-535.
9. Lee BL, Delahunty T, Safrin S: The hydroxylamine of sulfamethoxazole and adverse reactions in patients with acquired immunodeficiency syndrome. Clin Pharmacol Ther 1994;56:184-189.
10. Kalow WK, Tang BK: Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities. Clin Pharmacol Ther 1991;50:508-519.
11. Eck HP, Gmunder H, Hartmann M, Petzoldt D, Daniel V, Droge W: Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol Chem Hoppe Seyler 1989;370:101-108.
12. de Quay B, Malinverni R, Lauterburg BH: Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 1992;6:815-819.
13. Malloy MH, Rassin DK, Gaull GE: A method for measurement of free and bound plasma cysteine. Anal Biochem 1981;113:407-415.
14. Muir KT, Jonkman JHG, Tang DS, Kunitani M, Riegelman S: Simultaneous determination of theophylline and its major metabolites in urine by reversed-phase ion-pair high-performance liquid chromatography. J Chromatogr A 1980;221;85-95.
15. Kalow W, Tang BK: Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking. Clin Pharmacol Ther 1991;49:44-48.
16. Relling MV, Lin JS, Ayers GD, Evans WE: Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther 1992;52:643-658.
17. Cribb AE, Spielberg SP, Griffin GP: N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. Drug Metab Dispos 1995; 23:406-414.
18. Buhl R, Holroyd KJ, Mastrangeli A, et al: Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 1989;2:1294-1298.
19. Staal FJ, Ela SW, Roederer M, Anderson MT, Herzenberg LA, Herzenberg LA: Glutathione deficiency and human immunodeficiency virus infection. Lancet 1992;339:909-912.
20. Rieder MJ, Krause R, Bird IA, Dekaban GA: Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and non-infected cells. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:134-140.
21. Cribb AE, Spielberg SP: Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine. Drug Metab Dispos 1990;18:784-787.